Similar articles

• Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.

  van Meerbeeck JP, Kramer GW, Van Schil PE, Legrand C, Smit EF, Schramel F, Tjan-Heijnen VC, Biesma B, Debruyne C, van Zandwijk N, Splinter TA, Giaccone G; European Organisation for Research and Treatment of Cancer-Lung Cancer Group. van Meerbeeck JP, et al. J Natl Cancer Inst. 2007 Mar 21;99(6):442-50. doi: 10.1093/jnci/djk093. J Natl Cancer Inst. 2007. PMID: 17374834 Clinical Trial.
• Neoadjuvant therapy for resectable non-small cell lung cancer with mediastinal lymph node involvement.

  Tieu BH, Sanborn RE, Thomas CR Jr. Tieu BH, et al. Thorac Surg Clin. 2008 Nov;18(4):403-15. doi: 10.1016/j.thorsurg.2008.07.004. Thorac Surg Clin. 2008. PMID: 19086609 Review.
• [Multimodal treatment of non small cell lung cancer].

  Stoelben E, Digel W, Henke M, Passlick B. Stoelben E, et al. Zentralbl Chir. 2006 Apr;131(2):110-4. doi: 10.1055/s-2006-921534. Zentralbl Chir. 2006. PMID: 16612776 German.
• [On ''Multimodal treatment of clinical non-small cell N2 bronchogenic carcinoma: what is the answer?''].

  González Aragoneses F. González Aragoneses F. Arch Bronconeumol. 2007 Mar;43(3):183-4; author reply 184. Arch Bronconeumol. 2007. PMID: 17386198 Spanish. No abstract available.
• The role of surgery in N2 non-small cell lung cancer.

  DeCamp MM Jr, Ashiku S, Thurer R. DeCamp MM Jr, et al. Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5033s-5037s. doi: 10.1158/1078-0432.CCR-05-9013. Clin Cancer Res. 2005. PMID: 16000610 Review.